HUGO-IABCR Congress 2010, Genomics, Biology and Breast Cancer Treatment
| Contributed by: | HUGO Admin |
| Originally posted: | 2nd July 2010: 9:14 am |
| Last updated: | 23rd July 2010: 9:19 am |
| Short URL: | http://gen2phen.org/node/23989 |
This conference jointly organised between the Human Genome Organisation (HUGO) and the International Association of Breast Cancer Research (IABCR) focuses on the intersection of Genomics , Biology, and Breast Cancer Treatment. Dramatic advances in our understanding of mammary gland development, breast cancer biology, and the genetics of cancer susceptibility have been propelled by genomic strategies and databases. We have redefined cancer classification, revealed the precise contours of estrogen receptor signaling, and identified the mammary gland stem cell. These fundamental advances are now converging to make an impact on the treatment of the disease. In this meeting, we will explore how we arrived to this point, and where we will be going to personalize breast cancer prevention and therapy. This conference will be relevant to clinicians, and researchers who wish to explore the extension of their work into this translational interface. In recognition of this, we will host also educational sessions that will expose basic scientists to clinical breast cancer treatment, and clinicians to the fundamental breast cancer research. In Singapore, we are working directly at the nexus of these three streams of clinical and basic sciences, and technology and are proud to host this exciting congress. So we invite you to attend this scientific gathering in our vibrant city-state.
Locations
| Attachment | Size |
|---|---|
| IABCR2010-alt2_02jul10.pdf | 101.16 KB |
